Table 2.
Variables | Group A (n = 383) | Group B (n = 297) | Group C (n = 22) | P value† | P value‡ |
---|---|---|---|---|---|
Largest tumor size (mm) | 14.4 ± 9.7 | 13.2 ± 9.9 | 13.6 ± 7.6 | 0.133 | 0.709 |
Multifocality | 106 | 70 | 3 | 0.251 | 0.216 |
Primary tumor location | 1 | 0.217 | |||
Upper | 108 | 84 | 3 | ||
Middle | 162 | 122 | 14 | ||
Lower | 103 | 80 | 3 | ||
Isthmus | 10 | 11 | 2 | ||
T classification | 0.384 | 0.655 | |||
T1 | 145 | 123 | 7 | ||
T2 | 12 | 8 | 1 | ||
T3 | 206 | 158 | 14 | ||
T4 | 20 | 8 | 0 | ||
N classification | 0.079 | 0.822 | |||
N0 | 132 | 122 | 8 | ||
N1 | 251 | 175 | 14 | ||
AJCC stage | |||||
I–II | 250 | 194 | 11 | 1 | 0.171 |
III–IV | 133 | 103 | 11 | ||
Gross extrathyroidal extension | 155 | 123 | 5 | 0.814 | 0.118 |
Number of harvested lymph nodes* | 12.2 ± 6.5 | 10.6 ± 6.1 | 11.7 ± 6.5 | 0.001 | 0.731 |
Number of metastatic lymph nodes* | 3.1 ± 4.2 | 2.5 ± 3.5 | 2.3 ± 3.2 | 0.024 | 0.368 |
*Central lymph nodes; †groups A vs B; ‡groups A vs C.
AJCC, American Joint Committee on Cancer.